Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 59OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Nasopharyngeal Cancer Recurrent 1Gynecologic Cancer 1Gallbladder Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Cisplatin 5Fluorouracil 4Capecitabine 4tislelizumab 2Radiation 2Gemcitabine 2toripalimab 1temoporfin 1nimotuzumab 1fludarabine 1Taxes 1Radiotherapy, Intensity-Modulated 1Maintenance Chemotherapy 1Drug Therapy 1Cyclophosphamide 1Cell Count 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Nasopharyngeal Carcinoma × Radiotherapy, Intensity-Modulated × Clear all
NCT06775756 2025-01-15

Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer

Fujian Cancer Hospital

Phase 3 Not yet recruiting
474 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡